NLNK : Summary for NewLink Genetics Corporation - Yahoo Finance

U.S. Markets closed

NewLink Genetics Corporation (NLNK)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.69+0.32 (+1.74%)
At close: 4:00PM EDT
People also watch
TKMRCMRXSRPTCLVSPTCT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close18.37
Open18.34
Bid15.05 x 3000
Ask26.00 x 100
Day's Range18.34 - 19.02
52 Week Range9.23 - 25.17
Volume266,999
Avg. Volume628,042
Market Cap546.11M
Beta2.42
PE Ratio (TTM)-6.36
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal6 days ago

    Vaunted Ebola Vaccine Faces Questions

    The deadly Ebola outbreak in West Africa two years ago, the worst in recorded history, led to a vaccine that seemingly would stop the next Ebola epidemic in its tracks. Now there are questions about that ...

  • Capital Cube9 days ago

    NewLink Genetics Corp. – Value Analysis (NASDAQ:NLNK) : April 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives NewLink Genetics Corp. a score of 14. Our analysis is based on comparing NewLink Genetics Corp. with the following peers – Eli Lilly and Company, Threshold Pharmaceuticals, Inc., Pfizer Inc., Sarepta Therapeutics, Inc., SIGA Technologies Inc, Johnson & Johnson, Sinovac Biotech Ltd. and Bristol-Myers Squibb Company (LLY-US, ... Read more (Read more...)

  • Should Gilead Sciences Acquire NewLink Genetics?
    Motley Fool9 days ago

    Should Gilead Sciences Acquire NewLink Genetics?

    NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.